Wgu Est1 Task 2

Nightingale Community Hospital identified a recent sentinel event involving the ambulatory surgical center. A sentinel event is defined as an unexpected occurrence involving death or serious physical or psychological injury, or the risk thereof (http://www.jointcommission.org/sentinel_event). A three year old female presented to the hospital on September 14th for a planned outpatient procedure. The child was accompanied by her mother. The mother registered the patient with the registrar prior to the procedure. The patient and her mother went to the pre-operative area to complete the informed consent and the necessary physical assessment. The pre-operative nurse obtained the necessary contact

Product production comes with many types of costs. Four of the most common costs are prevention costs, appraisal costs, internal failure costs and external failure costs. These four costs are called quality costs and are costs that all businesses that produce products will pay. The amount of money that will go to each cost is dependent on the amount spent on the other costs. In other words, an increase in one type of cost can result in a decrease in another. Businesses need to understand the nature of each cost in order to understand for which cost to budget.

Cognitive Development refers to the construction of the thought process that includes problem solving, remembering and the ability to make decisions, from childhood up to the adulthood stage. Cognitive/Intellectual Development is the ability to learn, reason, and analyze the fact that a process begins from infancy and progresses as the individual (Educational Psychology). Cognitive Development contains events that are logical, like thinking and remembering. Some factors remain the same throughout many of the theories on cognitive development. All theorists agree that people go through specific steps and/or

A. Nurse sensitive indicators are factors that are directly impacted by nursing.  There indicators fall into three categories; structure, process and outcomes of nursing care.  The structure indicators are the organizational piece of nursing care. These relates to the amount of staff on duty at a given time, how many RN's are on duty and experience level of the staff. For example, evidence indicates institutions with a higher number of RN’s possessing a Bachelor Degree in nursing result in improved patient outcomes. The process indicators measure nursing care such as patient assessment, patient care and intervention. These are the organizational policies and procedures of nursing.   The patient outcomes are indicators directly related to

is to protect the health, safety and wellbeing of the public and their healthcare needs.

In this paper I will discuss Pharmaceutical Research and Manufacturers of America (PhRMA) I will talk about its purpose, scope, design, application, and how they affect the healthcare economy.

Conducting a SWOTT analysis allows businesses to further understand both internal and external influential factors that could be impacting the company. Using this systematic method allows for the company to recognize their strengths, weaknesses, potential opportunities, threats, and business trends. Looking at both the internal and external factors within this analytical examination can allow businesses to assess where their company currently stands and where it must improve for the future. Economic, Legal, and Regulatory Forces and Trends

In the following sections I will discuss my thoughts for how the company can achieve long-term success by targeting a new international market and by pursuing partnerships with other pharmaceutical companies to ensure that when the Provenge patent expires, the company is positioned for FDA approval of additional patented drugs, as well as continued international presence.

For as long as civilization has existed, humans have been looking for ways to advance in the field of medicine in order to cure illness and elongate the human lifespan. This has led to many positives such as ground-breaking new discoveries, inventions, and vaccines. One aspect of medicine that has grown dramatically in the past decade is the pharmaceutical industry. The pharmaceuticals are responsible for the manufacturing and the distributing of medicine in the form of drugs. While the drugs main purpose is to help the sick, you cannot say the same for the pharmaceutical industry. Unfortunately, the pharmaceuticals discovered that the more we advance in the field of medicine, the more money there is for the taking. The World Health

Patents, for pharmaceutical companies such as GSK, are major as they secure the high sales, till it matures. Therefore, “ the pharma industry offers high visibility and predictability of future revenue “. (Froud Johal Leaver Williams, 2006 : 150)

Pfizer has become interested and is investing in biotechnology not only because of the patent potential, but also because the biologic compounds are significantly harder to copy by generic manufacturers (Lawler, 2007). Pfizer’s billions of dollars dedicated to research and development have been fueled by the search to be the first to patent a new blockbuster drug. The discovery of a blockbuster drug can make or break a company. In response to competition going global, Pfizer has done the same only to be forced to face problems with both counterfeiting and the protection of intellectual property (Kermani, 2006). Overall, Pfizer has been affected by global competition in numerous ways, and most of the actions Pfizer has taken as a result have made the company more profitable as a whole.

The global pharmaceutical industry is one that is seen to be riddled with misunderstanding and confusion; however, many of the questions emerging companies have can be answered by a thorough analysis of this industry and how these companies compare to one another on many different fronts. Analyzing the global pharmaceutical industry can bring to light how we in the United States compare on the grounds of industry attractiveness to our global counterparts.

Technological: The pharmaceutical industry has seen many modern scientific advances, this meant that in order to remain a big player a company must be constantly adapting their products in order to keep up with their competition. In order to achieve this companies must increase their investment and spending on research and development in order to encourage innovation. (McGee et al, 2005)

high growth rate – higher propotion of the global pharma market in the years to come

Lack of scientific productivity and innovation is one of the main issues the pharmaceutical industry is suffering from. Researchers and developers are under serious scrutiny and extreme safety standards by the Food and Drug Administration (FDA). This results in little room to innovate. There are fewer products being permitted and scientists are thus failing to reach potential in delivering care for patients and their own commercial profits. Companies do not take risks and therefore have bad portfolios. Pharmaceutical industries need to allocate the expense and the risks of backing research and development. Innovation is a must for developing pharmaceutical companies, and